Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.
Antibodies, Monoclonal
/ therapeutic use
Betacoronavirus
/ isolation & purification
COVID-19
Complement System Proteins
/ metabolism
Coronavirus Infections
/ complications
Humans
Immunity, Active
Immunosuppressive Agents
/ therapeutic use
Immunotherapy
Nervous System Diseases
/ complications
Pandemics
Pneumonia, Viral
/ complications
SARS-CoV-2
Vaccination
COVID-19
Disease modifying therapies
Immunotherapies
Infections risk
Multiple sclerosis
Journal
EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
01
05
2020
revised:
14
05
2020
accepted:
19
05
2020
pubmed:
15
6
2020
medline:
2
7
2020
entrez:
15
6
2020
Statut:
ppublish
Résumé
Immunosuppression and immunomodulation are valuable therapeutic approaches for managing neuroimmunological diseases. In times of the Coronavirus disease 2019 (COVID-19) pandemic, clinicians must deal with the question of whether immunotherapy should currently be initiated or discontinued in neurological patients. Uncertainty exists especially because different national medical associations publish different recommendations on the extent to which immunotherapies must be continued, monitored, or possibly switched during the current pandemic. Based on the most recently available data both about the novel coronavirus and the approved immunotherapies for neurological diseases, we provide an updated overview that includes current treatment strategies and the associated COVID-19 risk, but also the potential of immunotherapies to treat COVID-19.
Identifiants
pubmed: 32535547
pii: S2352-3964(20)30197-3
doi: 10.1016/j.ebiom.2020.102822
pmc: PMC7286830
pii:
doi:
Substances chimiques
Antibodies, Monoclonal
0
Immunosuppressive Agents
0
Complement System Proteins
9007-36-7
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102822Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Références
J Clin Med. 2019 Oct 04;8(10):
pubmed: 31590282
N Engl J Med. 2019 Aug 15;381(7):614-625
pubmed: 31050279
J Immunol. 2016 Feb 15;196(4):1541-9
pubmed: 26764035
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Front Microbiol. 2019 May 10;10:1057
pubmed: 31134045
Cell Mol Immunol. 2015 Sep;12(5):650-2
pubmed: 25482074
Mol Cell. 2014 Apr 24;54(2):273-80
pubmed: 24766891
Neurotherapeutics. 2013 Jan;10(1):77-88
pubmed: 23271506
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
Crit Care Med. 2014 Mar;42(3):e189-99
pubmed: 24335440
Nat Med. 2003 Apr;9(4):431-8
pubmed: 12612546
Nat Rev Neurol. 2020 Jan;16(1):56-62
pubmed: 31649335
Mol Immunol. 2010 Aug;47(13):2176-86
pubmed: 20603023
J Neuroimmunol. 2001 Jul 2;117(1-2):1-8
pubmed: 11430999
J Clin Invest. 2006 Nov;116(11):2935-44
pubmed: 17080194
Neurol Neuroimmunol Neuroinflamm. 2019 Dec 11;7(2):
pubmed: 31826986
Virol Sin. 2020 Jun;35(3):266-271
pubmed: 32125642
BioDrugs. 2008;22(2):85-100
pubmed: 18345706
Emerg Microbes Infect. 2015 May;4(5):e28
pubmed: 26060601
J Infect Dis. 2015 Dec 15;212(12):1904-13
pubmed: 26198719
J Infect. 2020 Jul;81(1):e13-e20
pubmed: 32283144
Oncologist. 2018 Aug;23(8):943-947
pubmed: 29622697
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
Emerg Microbes Infect. 2020 Dec;9(1):558-570
pubmed: 32172672
Trials. 2018 Jan 30;19(1):81
pubmed: 29382391
Int J Mol Sci. 2019 Nov 28;20(23):
pubmed: 31795084
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Eur J Neurol. 2013 Jun;20(6):975-80
pubmed: 23521577
Lancet Neurol. 2017 Dec;16(12):976-986
pubmed: 29066163
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr;369(4):428-33
pubmed: 14985941
Ther Adv Neurol Disord. 2019 Apr 01;12:1756286419836571
pubmed: 30967901
Sci Rep. 2016 Nov 16;6:37297
pubmed: 27849062
mBio. 2018 Oct 9;9(5):
pubmed: 30301856
Lancet Neurol. 2014 Mar;13(3):247-56
pubmed: 24461574
Pract Neurol. 2019 Feb;19(1):5-20
pubmed: 30498056
Crit Care. 2018 Oct 30;22(1):285
pubmed: 30373638
Immunotherapy. 2016 Jul;8(8):959-70
pubmed: 27381687
J Immunol. 2006 Apr 1;176(7):4284-95
pubmed: 16547266
J Gen Virol. 2013 Aug;94(Pt 8):1749-1760
pubmed: 23620378
Clin Exp Immunol. 1999 Jan;115(1):136-43
pubmed: 9933433
Mult Scler. 2016 Dec;22(14):1891-1892
pubmed: 27068554
Viruses. 2020 Feb 22;12(2):
pubmed: 32098422
Int J Mol Sci. 2015 Jul 20;16(7):16414-39
pubmed: 26204829
Nat Rev Microbiol. 2009 Feb;7(2):99-109
pubmed: 19148178
Clin Immunol. 2008 Mar;126(3):282-90
pubmed: 18226586
Adv Virus Res. 2016;96:219-243
pubmed: 27712625
Mult Scler. 2020 Aug;26(9):1083-1092
pubmed: 31172849
N Engl J Med. 2006 Mar 2;354(9):899-910
pubmed: 16510744
J Clin Med. 2016 Nov 24;5(12):
pubmed: 27886126
J Immunol. 2011 Mar 15;186(6):3289-93
pubmed: 21317388
PLoS One. 2014 Feb 14;9(2):e88716
pubmed: 24551142
J Virol. 2009 Apr;83(7):3039-48
pubmed: 19004938
J Gen Virol. 2014 Mar;95(Pt 3):571-577
pubmed: 24323636
Immunopharmacology. 2000 May;47(2-3):85-118
pubmed: 10878285
Eur J Immunol. 2017 Sep;47(9):1414-1426
pubmed: 28744851
Drugs. 2017 Oct;77(16):1755-1768
pubmed: 28905255
Mult Scler. 2018 Oct;24(12):1594-1604
pubmed: 28870107
Ann Neurol. 2006 May;59(5):748-54
pubmed: 16634035
Neurology. 2019 Oct 8;93(15):e1452-e1462
pubmed: 31515290
HIV Ther. 2009 May;3(3):269-282
pubmed: 32280376
J Virol. 1998 May;72(5):3812-8
pubmed: 9557664
Mult Scler. 2017 May;23(6):876-877
pubmed: 28290753
Lancet. 2019 Oct 12;394(10206):1352-1363
pubmed: 31495497
Adv Exp Med Biol. 2012;946:147-59
pubmed: 21948367
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
N Engl J Med. 2019 Nov 28;381(22):2114-2124
pubmed: 31774956
Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1281-5
pubmed: 15571246
Viruses. 2013 May 22;5(5):1250-60
pubmed: 23698397
J Infect. 2013 Dec;67(6):606-16
pubmed: 24096239
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
J Neurol. 2018 Jun;265(6):1251-1258
pubmed: 29372387
Lancet. 2002 Dec 21-28;360(9350):2018-25
pubmed: 12504397
Rev Med Virol. 2003 Nov-Dec;13(6):387-98
pubmed: 14625886
Mult Scler J Exp Transl Clin. 2015 Jan-Dec;1:
pubmed: 26550483
Neurol Neuroimmunol Neuroinflamm. 2018 Jul 09;5(5):e475
pubmed: 29998157
Diagn Interv Imaging. 2020 May;101(5):323-324
pubmed: 32278585
Autoimmun Rev. 2019 Feb;18(2):113-122
pubmed: 30572131
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Blood. 2008 Apr 1;111(7):3439-41
pubmed: 18195093
BMC Infect Dis. 2016 Apr 21;16:174
pubmed: 27097824
Lancet. 2015 Sep 5;386(9997):974-81
pubmed: 26135706
Mediators Inflamm. 2010;2010:781235
pubmed: 20981241
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
Antiviral Res. 2015 Mar;115:9-16
pubmed: 25542975
Expert Rev Hematol. 2011 Dec;4(6):619-25
pubmed: 22077526
Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84
pubmed: 24841269
Nat Rev Neurol. 2016 Apr;12(4):217-33
pubmed: 26943779
N Engl J Med. 2011 Oct 6;365(14):1293-303
pubmed: 21991951
Am J Hematol. 2020 Jul;95(7):876-878
pubmed: 32282956
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
Curr Opin Infect Dis. 2016 Aug;29(4):319-29
pubmed: 27257797
N Engl J Med. 2017 Jan 19;376(3):209-220
pubmed: 28002688
Am J Pathol. 1998 Oct;153(4):1257-66
pubmed: 9777957
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Neurology. 2019 Sep 24;93(13):584-594
pubmed: 31462584
N Engl J Med. 2010 Feb 4;362(5):387-401
pubmed: 20089952
N Engl J Med. 2017 Jan 19;376(3):221-234
pubmed: 28002679
Ther Adv Neurol Disord. 2019 Mar 28;12:1756286419836913
pubmed: 30944586
Biochem Pharmacol. 2019 May;163:472-480
pubmed: 30880061
J Neurol. 1997 Sep;244(9):542-7
pubmed: 9352450
Nat Med. 2018 Jun;24(6):739-748
pubmed: 29808007
Neurology. 2003 Nov 25;61(10):1438-40
pubmed: 14638974
Mult Scler. 2014 Nov;20(13):1792-3
pubmed: 24866203
Expert Rev Clin Immunol. 2018 Feb;14(2):137-153
pubmed: 29318902
N Engl J Med. 1987 Sep 17;317(12):770
pubmed: 3306381
J Virol. 2010 Jan;84(2):1198-205
pubmed: 19864379
Mult Scler. 2020 May;26(6):737-740
pubmed: 32298205
Crit Care Med. 2007 Dec;35(12):2677-85
pubmed: 18074464